A laboratory for validating cancer biomarkers
Biomarker Reference Laboratory
This study is looking to improve how we test for prostate cancer and decide on treatments by developing new, non-invasive tests that can help identify how aggressive the cancer is and monitor patients who are being watched closely, so that you can get the best care possible.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10890730 on NIH RePORTER |
What this research studies
This research focuses on the validation of biomarkers for prostate cancer, aiming to improve diagnostic methods and treatment decisions. The laboratory at Johns Hopkins will develop and refine assays to assess cancer aggressiveness and monitor patients under active surveillance. By utilizing advanced technologies in proteomics and bioinformatics, the project seeks to create non-invasive tests that can help identify patients at risk of disease progression. Patients may benefit from more accurate assessments and tailored treatment options based on these biomarkers.
Who could benefit from this research
Good fit: Ideal candidates for this research include men diagnosed with prostate cancer who are considering active surveillance or are currently under such management.
Not a fit: Patients with non-prostate cancers or those who are not candidates for active surveillance may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more precise and personalized treatment strategies for prostate cancer patients.
How similar studies have performed: Previous research has shown success in biomarker validation for cancer diagnostics, indicating a promising approach in this area.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Chan, Daniel Wanyui — Johns Hopkins University
- Study coordinator: Chan, Daniel Wanyui
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.